Holly has spent nearly twenty years advising biotech, diagnostic and medical device companies across multiple areas of law, including IP, commercial transactions, litigation, regulatory and compliance. She started her career at Arnold & Porter, LLP in Washington, D.C. and spent a year as professional staff for the Science and Technology Committee in the U.S. House of Representatives. She has served as an advisor to Trovagene, BioTheranostics, Aktana, Gensignia, GenSprea and, most recently, is the Head of Strategic Assets and General Counsel at Drawbridge Health. She holds a BS in Biochemistry and a JD from the University of Michigan, as well as an MBA from Wharton at the University of Pennsylvania.
